Lindsay A Rosenwald Md bought $2.7M of FBIO
President, CEO & Chairman at Fortress Biotech, Inc.. 1,567,515 shares at an average of $1.70, traded Nov 14, 2023, filed Nov 16, 2023.
Score components
- +25RoleCEO
- +25Trade size$2.7M at market
- +10Relative to holdingsHoldings up 152%
- 0Price contextNo price history yet
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-23-119188, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 14, 2023 | POpen-market purchase COMMON STOCK, PAR VALUE $0.001 | +1,567,515 | $1.70 | $2.7M | 2,597,440 | Nov 16, 2023 |
| Nov 14, 2023 | POpen-market purchase Warrants to purchase Common Stockderivative | +1,567,515 | $0.00 | $0 | 1,567,515 | Nov 16, 2023 |
Related signals
Other insiders at Fortress Biotech, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 75Notable | FBIObuy Fortress Biotech, Inc. | Lindsay A Rosenwald Md PRESIDENT, CEO & CHAIRMAN | $1.4M 763,359 shares | +26% | |
| 44Moderate | Fortress Biotech, Inc. | Lindsay A Rosenwald Md President, CEO & Chairman | $37k 5,000 shares | +4% | |
| 38Weak | Fortress Biotech, Inc. | David Jin Chief Financial Officer | $3,750 500 shares | - | |
| 44Moderate | Fortress Biotech, Inc. | Lindsay A Rosenwald Md President, CEO & Chairman | $37k 5,000 shares | +4% | |
| 44Moderate | Fortress Biotech, Inc. | Lindsay A Rosenwald Md President, CEO & Chairman | $37k 5,000 shares | +4% | |
| 39Weak | Fortress Biotech, Inc. | Lindsay A Rosenwald Md President, CEO & Chairman | $33k 20,000 shares | +1% | |
| 20Weak | FBIOsell Fortress Biotech, Inc. | Dov Klein director | $19k 10,000 shares | -16% | |
| 20Weak | FBIObuy Fortress Biotech, Inc. | Lindsay A Rosenwald Md President, CEO & Chairman | $18k 10,000 shares | +0% | |
| 40Moderate | FBIObuy Fortress Biotech, Inc. | Lindsay A Rosenwald Md President, CEO & Chairman | $119k 50,000 shares | +2% | |
| 39Weak | Fortress Biotech, Inc. | Michael S Weiss See Remarks | $250k 147,058 shares | +15% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.